DC/肿瘤融合细胞疫苗制备规范化研究
出处
《实用肿瘤杂志》
CAS
北大核心
2010年第3期260-262,共3页
Journal of Practical Oncology
基金
国家教育部新世纪优秀人才支持计划项目(NCET-08-0923)
云南省应用基础研究重点项目(2008CC006)
昆明市科技计划重点项目(昆科07S060202)
云南省中青年学术技术带头人后备人才培养基金(2006PY01-12)
参考文献16
-
1Villablanca EJ, Raccosta L, Zhou D, et al. Tumor- mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses [ J]. Nat Med, 2010, 16 ( l ) :98 - I05. 被引量：1
-
2Chan CW, Housseau F. The ' kiss of death' by dendritic ceils to cancer cells [ J]. Cell Death Differ,2008,15 ( 1 ) : 58 - 69. 被引量：1
-
3Dumitriu IE, Dunbar DR, Howie SE, et al. Human dendritic ceils produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4 + CD25+ Foxp3 + regulatory T cells [J]. J Immunol, 2009,182 ( 5 ) :2795 - 2807. 被引量：1
-
4Savai R, Schermuly RT, Pullamsetti SS, et aI. A combination hybrid-based vaccination/adoptive cellular therapy to prevent tumor growth by involvement of T cells [ J ]. Cancer Res,2007,67 ( 11 ) : 5443 - 5453. 被引量：1
-
5Tamai H, Watanabe S, Zheng R, et al. Effective treatment of spontaneous metastases derived from a poorly immunogenie murine mammary carcinoma by combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cells [ J]. Clin Immunol,2008,127 ( 1 ) :66 - 77. 被引量：1
-
6Zhou J,Weng D,Zhou F, et al. Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti- tumor activity : in vitro results and clinical responses [ J]. Cancer Immunol Immunother,2009,58(10) :1587 - 1597. 被引量：1
-
7Avigan DE, Vasir B, George D J, et al. Phase I / II study of vaccination with electrofused aUogeneic dendritic cells/ autologous tumor-derived cells in patients with stage IV renal cell carcinoma [ J ]. J Immunother, 2007,30 ( 7 ) : 749 - 761. 被引量：1
-
8Koido S, Nikrui N, Ohana M, et al. Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use [ J ]. Gynecol Oncol, 2005,99 (2) -462 - 471. 被引量：1
-
9Wei Y, Sticca RP, Holmes LM, et al. Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses [ J ]. Int J Oncol, 2006,28 ( 3 ) : 585 - 593. 被引量：1
-
10Hock BD, Roberts G, McKenzie JL, et al. Exposure to the eleetrofusion process earl increase the imrnuno-genicity of human cells [ J]. Cancer Immunol Immunother,2005,54 (9) : 880 - 890. 被引量：1
-
1戴鹏,林云,张晓勇,钟优,李丹旦.腹腔镜结直肠癌根治术规范化研究[J].中国现代医生,2016,54(19):57-59. 被引量：5
-
2卫立辛,钱卫珠,闰振林,王皓,刘彦君,罗明,赵健,施军霞,沈锋,吴孟超,郭亚军.细胞融合大鼠肝癌疫苗制备及免疫相关表型分析[J].中国肿瘤临床,1999,26(3):219-221.
-
3战姝妍,姚军.预测宫颈癌新辅助化疗疗效的细胞标记物[J].中国医药导报,2011,8(19):13-14.
-
4张坤,余佩武,高朋芬,饶云.胃癌-树突状细胞融合细胞疫苗制备及其形态学观察[J].局解手术学杂志,2005,14(5):301-303. 被引量：5
-
5宋飞雪,张筠.树突状细胞及其在血液系统肿瘤免疫治疗中的应用[J].白血病．淋巴瘤,2004,13(1):55-58. 被引量：2
-
6吴尘轩,杜智.树突状细胞与肝细胞癌免疫治疗[J].国际肿瘤学杂志,2006,33(5):366-369.
-
7孙桥,庞剑.非小细胞肺癌生物治疗及其联合用药[J].医药前沿,2016,0(22):11-13.
-
8王剑虹,江丽君.癌症疫苗[J].国外医学（预防．诊断．治疗用生物制品分册）,2001,24(1):14-16. 被引量：1
-
9叶序卷,姚兰,贾钰铭.树突状细胞及胃肠激素与肿瘤三者关系间的研究进展[J].肿瘤预防与治疗,2008,21(2):229-230.
-
10付贤,肖家全.树突状细胞在去势抵抗前列腺癌免疫治疗中的研究进展[J].国际泌尿系统杂志,2014,34(4):559-563. 被引量：2
